Is tadalafil (PDE5 inhibitor) the first-line treatment for erectile dysfunction (ED)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Tadalafil is a first-line treatment for erectile dysfunction (ED) due to its efficacy and safety profile, as recommended by the American College of Physicians 1. The American College of Physicians strongly recommends initiating therapy with a PDE-5 inhibitor, such as tadalafil, in men who seek treatment for ED and do not have a contraindication to PDE-5 inhibitor use 1. Some key points to consider when prescribing tadalafil include:

  • The choice of a specific PDE-5 inhibitor should be based on individual preferences, including ease of use, cost of medication, and adverse effects profile 1
  • Tadalafil has been shown to demonstrate statistically significant and clinically relevant improvements in sexual intercourse and erectile function in patients with ED 1
  • Common side effects of tadalafil include headache, indigestion, back pain, muscle aches, flushing, and nasal congestion
  • Tadalafil should not be taken with nitrates or certain other medications, and patients with cardiovascular disease may require evaluation before starting treatment
  • The dosage of tadalafil can range from 5-20mg taken as needed before sexual activity, or at a lower daily dose of 2.5-5mg for continuous therapy, with effects lasting up to 36 hours. It is essential to individualize treatment decisions and consider the clinical presentation and physical findings of each patient, as the evidence is insufficient to compare the efficacy and adverse effects of different PDE-5 inhibitors for the treatment of ED 1.

From the FDA Drug Label

The efficacy and safety of tadalafil in the treatment of erectile dysfunction has been evaluated in 22 clinical trials of up to 24-weeks duration, involving over 4000 patients. Tadalafil, when taken as needed up to once per day, was shown to be effective in improving erectile function in men with erectile dysfunction (ED)

  • Tadalafil is a PDE5 inhibitor that has been shown to be effective in improving erectile function in men with erectile dysfunction (ED) 2.
  • The FDA drug label supports the use of tadalafil as a treatment for ED, with studies demonstrating its efficacy and safety in improving erectile function 2, 2.
  • Key findings from the studies include:
    • Tadalafil was effective in improving erectile function in men with ED, with significant improvements in the EF domain of the IIEF questionnaire and Questions 2 and 3 of the SEP diary.
    • Tadalafil was shown to be effective when taken as needed, up to once per day, and when taken once daily.
  • Conclusion: Based on the available evidence, tadalafil can be considered a first-line treatment for erectile dysfunction (ED) 2, 2.

From the Research

Tadalafil as First-Line Treatment for Erectile Dysfunction

  • Tadalafil is considered an effective drug in treating erectile dysfunction (ED), with its clinical efficacy confirmed by numerous research studies 3, 4, 5.
  • As a long-acting phosphodiesterase type 5 (PDE5) inhibitor, tadalafil is administered orally as the first-line therapy for ED, with a prolonged action of 36 hours 4, 5.
  • The efficacy and safety of tadalafil have been confirmed by many clinical studies in the treatment of ED in general patients, elderly patients, and those with diabetes mellitus or spinal cord injury or after prostate cancer surgery 4, 5.

Comparison with Other PDE5 Inhibitors

  • A trade-off network meta-analysis compared the efficacy and adverse events of various PDE5 inhibitors, including tadalafil, sildenafil, vardenafil, and avanafil 6.
  • The analysis found that tadalafil 10mg had intermediate efficacy but the lowest overall rate of adverse events, making it a suitable option for patients who prioritize tolerability 6.
  • Sildenafil 50mg had the greatest efficacy but also the highest rate of overall adverse events, while vardenafil 10mg and avanafil 100mg had similar overall adverse events but lower global efficacy 6.

Clinical Efficacy and Safety

  • Clinical trials have shown that tadalafil significantly enhances erectile function across a wide range of etiologies and provides a prolonged period of effectiveness independent of food or alcohol 5, 7.
  • Tadalafil has been found to be effective in improving the erectile function of ED patients, including those with various comorbid conditions, and can help ED patients regain morning erection and recover confidence 3, 4.
  • The most frequent adverse events associated with tadalafil are headache, dyspepsia, back pain, and myalgia 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Efficacy of tadalafil for erectile dysfunction: an updated review].

Zhonghua nan ke xue = National journal of andrology, 2007

Research

[Efficacy and safety of tadalafil for erectile dysfunction: an updated review].

Zhonghua nan ke xue = National journal of andrology, 2009

Research

Tadalafil in the treatment of erectile dysfunction.

Current urology reports, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.